Can Jakafi (ruxolitinib) cause diarrhea?
Yes. Diarrhea is a known side effect of Jakafi (ruxolitinib). People taking it can experience gastrointestinal symptoms, including diarrhea [1].
What should I do if I get diarrhea while taking Jakafi?
If you develop diarrhea after starting or while on Jakafi, the practical next step is to tell your prescriber so they can advise whether you need supportive care, dose adjustment, or evaluation for other causes [1]. If the diarrhea is severe or you have warning signs (like dehydration or inability to keep fluids down), seek urgent medical guidance.
When is diarrhea on Jakafi considered a red flag?
Seek prompt medical care if diarrhea is severe, persistent, or comes with signs of dehydration (very dry mouth, dizziness, fainting, reduced urination) or other concerning symptoms such as blood in stool, high fever, or worsening weakness. Your clinician may need to rule out infections or other problems unrelated to the medication and decide whether Jakafi should be held or adjusted [1].
Could diarrhea be from an infection or something else, not the medicine?
It can be. Symptoms like diarrhea can come from causes other than Jakafi (for example, infections). Because ruxolitinib can affect immune function, clinicians often take diarrhea seriously and evaluate for infectious causes when symptoms are more than mild or last longer than expected [1].
What treatments are used for diarrhea while on Jakafi?
Supportive treatments are commonly used for mild diarrhea (for example, oral hydration and symptom-directed care), but what’s appropriate depends on severity and duration. Because the right approach can require ruling out complications or infection, management should be coordinated with your prescriber rather than self-treating indefinitely [1].
What’s the difference between mild diarrhea vs severe diarrhea in practice?
Mild diarrhea is typically manageable with hydration and does not rapidly worsen. Severe or rapidly worsening diarrhea usually triggers medical assessment, possible stool/infection evaluation, and possible changes to Jakafi dosing or interruption, depending on the clinical picture [1].
Do diarrhea risk and severity differ by dose or treatment duration?
The likelihood and intensity of side effects can vary among individuals and may relate to dosing. If diarrhea occurs, your prescriber can review your dose and overall regimen to decide whether adjustments are needed [1].
---
Sources
- FDA label for JAKAFI (ruxolitinib)